1 / 5

Vaccine Market is Projected to Reach a Value of US$ 48.0 Bn by 2025

U.S. vaccine market was valued at USD 12.8 billion in 2013 and is expected to grow at a CAGR of 4.3% from 2014 to 2020, to reach an estimated value of USD 17.3 billion in 2020.

pharmahealth
Télécharger la présentation

Vaccine Market is Projected to Reach a Value of US$ 48.0 Bn by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ©2019 Transparency Market Research, All Rights Reserved Vaccine Market (Human Vaccines: Hepatitis, Influenza, Meningococcal, Pneumococcal, HPV, Combination Vaccines; Animal Vaccines: Canine, Feline, Porcine, Bovine, Ovine, Poultry and Equine Forecast 2014 - 2020 ©2019 Transparency Market Research, All Rights Reserved

  2. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Market Analysis, by Component Chapter 6 Market Analysis, by Data Type Chapter 7 Market Analysis, by Application Chapter 8 Market Analysis, by Region Chapter 9 Competition Landscape Chapter 10 Company Profiles Chapter 11 Key Takeaways

  3. ©2019 Transparency Market Research, All Rights Reserved Vaccine Market: Snapshot A vaccine is a biological preparation of killed forms of microbes, living attenuated organisms, living fully virulent organisms, a microbe’s toxins or one of its surface proteins. • • The U.S. human vaccine market can be classified into pediatric and adult vaccines, in terms of the type of vaccines. • Rising Cases of Vector Borne Diseases to Propel Market • Increasingly strict guidelines and regulations for the lengthy and time consuming approval process has resulted in the increase in cost of several new vaccines. ©2019 Transparency Market Research, All Rights Reserved

  4. ©2019 Transparency Market Research, All Rights Reserved Reports Highlights • U.S. vaccine market was valued at USD 12.8 billion in 2013 and is expected to grow at a CAGR of 4.3% from 2014 to 2020, to reach an estimated value of USD 17.3 billion in 2020. • Key Players – • GlaxoSmithKline plc, Merck & Co., Inc., Novartis International AG, Pfizer, Ltd., Sanofi, Boehringer Ingelheim and Zoetis, Inc. ©2019 Transparency Market Research, All Rights Reserved Request Sample

  5. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U

More Related